Literature DB >> 7582488

No evidence for a role of muscarinic M2 receptors in functional antagonism in bovine trachea.

A F Roffel1, H Meurs, C R Elzinga, J Zaagsma.   

Abstract

1. The functional antagonism between methacholine- or histamine-induced contraction and beta-adrenoceptor-mediated relaxation was evaluated in bovine tracheal smooth muscle in vitro. In addition, the putative contribution of muscarinic M2 receptors mediating inhibition of beta-adrenoceptor-induced biochemical responses to this functional antagonism was investigated with the selective muscarinic antagonists, pirenzepine (M1 over M2), AF-DX 116 and gallamine (M2 over M3), and hexahydrosiladiphenidol (M3 over M2). 2. By use of isotonic tension measurement, contractions were induced with various concentrations of methacholine or histamine, and isoprenaline concentration-relaxation curves were obtained in the absence or presence of the muscarinic antagonists. Antagonist concentrations were chosen so as to produce selective blockade of M2 receptors (AF-DX 116 0.1 microM, gallamine 30 microM), or half-maximal blockade of M3 receptors (pirenzepine 0.1 microM, AF-DX 116 0.5 microM, hexahydrosiladiphenidol 0.03 microM). Since these latter antagonist concentrations mimicked KB values towards bovine tracheal smooth muscle M3 receptors, antagonist-induced decreases in contractile tone were compensated for by doubling the agonist concentration. 3. It was found that isoprenaline-induced relaxation of bovine tracheal smooth muscle preparations was dependent on the nature and the concentration of the contractile agonist used. Thus, isoprenaline pD2 (-log EC50) values were decreased 3.7 log units as a result of increasing cholinergic tone from 22 to 106%, and 2.4 log units by increasing histamine tone over a similar range. Furthermore, maximal relaxability of cholinergic tone decreased gradually from 100% at low to only 1.3% at supramaximal contraction levels, whereas with histamine almost complete relaxation was maintained at all concentrations applied. As a result, isoprenaline relaxation was clearly hampered with methacholine compared to histamine at equal levels of contractile tone.4. In the presence of gallamine, isoprenaline relaxation was facilitated for most concentrations of methacholine, and for all concentrations of histamine. These changes could be explained by the decreased contraction levels for both contractile agonists in the presence of gallamine.5. Isoprenaline-induced relaxation of cholinergic contraction was also facilitated by AF-DX 116 as well as by pirenzepine and hexahydrosiladiphenidol, and these (small) changes were again related to the(small) decreases in cholinergic contraction levels that were present in these experiments despite the additional administration of the agonist to readjust contractile tone. Similarly, changes in isoprenaline relaxation of histamine-induced tone could be explained by different contraction levels.6. These results can be explained by the sole involvement of muscarinic M3 receptors, and provide no evidence for a role of muscarinic M2 receptors in functional antagonism in bovine trachea. Furthermore,they stress the importance of taking into account non-cholinergic controls as well as contraction levels in these experiments.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7582488      PMCID: PMC1908503          DOI: 10.1111/j.1476-5381.1995.tb14984.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  31 in total

1.  Allosteric interactions at the m1, m2 and m3 muscarinic receptor subtypes.

Authors:  N H Lee; E E el-Fakahany
Journal:  J Pharmacol Exp Ther       Date:  1991-02       Impact factor: 4.030

2.  Ligand binding and G protein coupling of muscarinic receptors in airway smooth muscle.

Authors:  P A Lucchesi; C R Scheid; F D Romano; M E Kargacin; D Mullikin-Kilpatrick; H Yamaguchi; T W Honeyman
Journal:  Am J Physiol       Date:  1990-04

3.  Muscarinic M2 receptors in bovine tracheal smooth muscle: discrepancies between binding and function.

Authors:  A F Roffel; C R Elzinga; R G Van Amsterdam; R A De Zeeuw; J Zaagsma
Journal:  Eur J Pharmacol       Date:  1988-08-09       Impact factor: 4.432

4.  Identification of three muscarinic receptor subtypes in rat lung using binding studies with selective antagonists.

Authors:  A D Fryer; E E el-Fakahany
Journal:  Life Sci       Date:  1990       Impact factor: 5.037

5.  Muscarinic receptor reserve and beta-adrenergic sensitivity in tracheal smooth muscle.

Authors:  S J Gunst; J Q Stropp; N A Flavahan
Journal:  J Appl Physiol (1985)       Date:  1989-09

6.  Role of phosphoinositide metabolism in human bronchial smooth muscle contraction and in functional antagonism by beta-adrenoceptor agonists.

Authors:  R G Van Amsterdam; H Meurs; R E Ten Berge; N C Veninga; F Brouwer; J Zaagsma
Journal:  Am Rev Respir Dis       Date:  1990-11

7.  Characterization of the muscarinic receptor subtype involved in phosphoinositide metabolism in bovine tracheal smooth muscle.

Authors:  A F Roffel; H Meurs; C R Elzinga; J Zaagsma
Journal:  Br J Pharmacol       Date:  1990-02       Impact factor: 8.739

8.  Muscarinic cholinergic inhibition of cyclic AMP accumulation in airway smooth muscle. Role of a pertussis toxin-sensitive protein.

Authors:  R M Sankary; C A Jones; J M Madison; J K Brown
Journal:  Am Rev Respir Dis       Date:  1988-07

9.  Reserpine-induced post-receptor reduction in muscarinic-mediated airway smooth muscle contraction.

Authors:  R W Gardier; H S Blaxall; L N Killian; J Cunningham
Journal:  Life Sci       Date:  1991       Impact factor: 5.037

10.  Muscarinic receptor subtypes in guinea pig airways.

Authors:  E B Haddad; Y Landry; J P Gies
Journal:  Am J Physiol       Date:  1991-10
View more
  4 in total

1.  Second M3 muscarinic receptor binding site contributes to bronchoprotection by tiotropium.

Authors:  Loes E M Kistemaker; Carolina R S Elzinga; Christofer S Tautermann; Michael P Pieper; Daniel Seeliger; Suraya Alikhil; Martina Schmidt; Herman Meurs; Reinoud Gosens
Journal:  Br J Pharmacol       Date:  2019-07-02       Impact factor: 8.739

2.  Functional interactions between muscarinic M2 receptors and 5-hydroxytryptamine (5-HT)4 receptors and beta 3-adrenoceptors in isolated oesophageal muscularis mucosae of the rat.

Authors:  R M Eglen; B Peelle; M T Pulido-Rios; E Leung
Journal:  Br J Pharmacol       Date:  1996-10       Impact factor: 8.739

3.  Characteristics of cyanopindolol analogues active at the beta 3-adrenoceptor in rat ileum.

Authors:  A J Hoey; C M Jackson; G G Pegg; M N Sillence
Journal:  Br J Pharmacol       Date:  1996-10       Impact factor: 8.739

4.  Muscarinic receptor subtypes and signalling involved in the attenuation of isoprenaline-induced rat urinary bladder relaxation.

Authors:  Lambertus P W Witte; Noach de Haas; Mathai Mammen; Eric L Stangeland; Tod Steinfeld; Jayashree Aiyar; Martin C Michel
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2011-09-24       Impact factor: 3.000

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.